Cleveland BioLabs Inc (NASDAQ:CBLI)
| 1.60 Data as of May 22 |  +0.01 / +0.63%Today’s Change | 1.20 Today|||52-Week Range 2.95 | +20.30% Year-to-Date |
Latest CBLI News | Press Releases
No recent news for Cleveland BioLabs Inc.
Today’s Trading
| Previous close | 1.59 |
| Today’s open | 1.61 |
| Day’s range | 1.59 - 1.67 |
| Volume | 110,233 |
| Average volume (3 months) | 259,597 |
| Market cap | $71.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -308.33% |
| Earnings growth (this year) | -13.61% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -59.38% |
| P/E ratio | NM |
| Price/Sales | 13.93 |
| Price/Book | 11.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IGIGI Laboratories Inc | -0.02 | -1.22% |
| --Ophthalix Inc | 0.00 | 0.00% |
| TKMRTekmira Pharmaceutic... | -0.09 | -1.87% |
| ORMPOramed Pharmaceutica... | -0.69 | -6.76% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $3.6M |
| Annual profit (last year) | -$18.2M |
| Net profit margin | -510.66% |
Profile
Sector Health Technology |
Industry Biotechnology |
President & Director Michael Fonstein, PhD |
Chief Executive Officer, COO & Director Yakov Kogan, PhD, MBA |
Corporate headquarters Buffalo, New York |
Forecasts
